Bioject Medical Technologies Inc fka BJCT

[illegal_alias]

This note at the bottom of the order leads me to believe that Bioject did respond:

Each Respondent other than Catalyst Resource Group, Inc., was served with the OIP by December 29, 2015, by USPS Express Mail delivery or attempted delivery at “the most recent address shown
on [its] most recent filing with the Commission.”

The latest 8-K uses the same address of the Tigard, OR hq, so I assume that the SEC at least now has a current address.

To allow time for Answers, the hearing will be postponed sine die, and a prehearing conference will be held by telephone on February 26, 2016, at 11:00 a.m. EST, if the proceeding has not been resolved by then.

So, I guess we are in trading suspension limbo until next month.

According to the bio on the BJCT website http://www.bioject.com/about/bios#chow , CEO Chow supposedly has some expertise in SEC filing. So, why did he let this happen?